(Q69545467)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

review article

1 reference

title

[Alpha-glucosidase inhibitors: a new therapeutic approach in diabetes and functional hypoglycemia] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

1 reference

J M Brogard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

B Willemin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

J F Blicklé

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

A M Lamalle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

A Stahl

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

publication date

1 July 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

Revue de Médecine Interne

3 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

page(s)

365-374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

Sucrose malabsorption in man after ingestion of alpha-glucosidehydrolase inhibitor

3 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Glycemic index of foods: a physiological basis for carbohydrate exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

The effects of theα-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: Dose-time-response relationships in man

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Long-term treatment of sulphonylurea-treated diabetics with the ?-glucosidase inhibitor Bay g 5421 (Acarbose)

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Effect of the?? glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Acarbose. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Effect of 1-desoxynojirimycin derivatives on small intestinal disaccharidase activities and on active transport in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

The effect of a 1-deoxynojirimycin derivative on post-prandial blood glucose and insulin levels in healthy black and white volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Effect of two new alpha-glucosidase inhibitors in insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Effects of prolonged administration of two new alpha-glucosidase inhibitors on blood glucose control, insulin requirements and breath hydrogen excretion in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Effects of the alpha-glucosidase inhibitor 1 desoxynojirimycin (Bay m 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Smoothing effect of a new alpha-glucosidase inhibitor BAY m 1099 on blood glucose profiles of sulfonylurea-treated type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Effect of an alpha-glucosidase inhibitor (BAY m 1099) on post-prandial blood glucose and insulin in type II diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Effects of BAYm 1099, new alpha-glucosidase inhibitor, on acute metabolic responses and metabolic control in NIDDM over 1 mo.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

Miglitol may have a blood glucose lowering effect unrelated to inhibition of alpha-glucosidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2889%2980039-6

7 January 2021

10.1016/S0248-8663(89)80039-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2678346%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

1 reference